1[1]Bingley PJ, Bonifacio E, Mueller PW. Diabetes antibody standardization program: first assay proficiency evaluation. Daibetes 2003;52:1128- 1136.
2[2]Krischer JP, Cuthbertson DD, Yu L, et al. Screening strategies for the indentificstion of multiple antibody - positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003;88:103-108.
3[3]Hamalainen AM, Knip M. Autoimmunity and familial risk or type 1 diabetes. Curr Diab Rep 2002; 2: 347 - 353.
4[4]Hamalainen AM, Ilonen J, Simell O, et al. Prevalence and fate of type 1 diabetes - associated autoantibodies in cord blood samples from newborn infants of non - diabetic mothers. Dibetes Metab Res Rev 2002;18:57-63.
5[5]Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (Latent autoimmune diabetes of the adult): Definition, characterization, and potential prevention. Diabetes Care 2001;24:1460 - 1467.
7[7]Greenbaum CJ, Harrison LC. Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes. Diabetes 2003; 52:1059 - 1065.
8[8]Hathout EH, Hartwick N, Fagoaga OR, et al. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Pediatrics 2003;111:860- 863.
9[9]Bo S, Menato G, Pinach S, et al. Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta - cell antigens. Diabet Med 2003 ;20: 64 - 68.
10[10]Borg H, Gottsater A, Landin - olsson M, et al. High levels of antigen - specific islet antibodies predict future β - cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 2001;86:3032- 3038.
2J. Seissler,J. J. J. de Sonnaville,N. G. Morgenthaler,H. Steinbrenner,D. Glawe,U. Y. Khoo-Morgenthaler,M. S. Lan,A. L. Notkins,R. J. Heine,W. A. Scherbaum. Immunological heterogeneity in Type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease[J] 1998,Diabetologia(8):891～897
